Latest filing published 07 Jul 2026 for Monopar Therapeutics Inc., €424k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Arthur Klausner: trading record in brief
This profile gathers the share dealings of Arthur Klausner in Monopar Therapeutics. Between 7 July 2026 and 8 July 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 10 July 2026 came the latest disclosure, a transaction for €418k in Monopar Therapeutics. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arthur Klausner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$97.05Class ASEC144:0001628280-26-047461
1 of 1 declaration
